Aberdeen Group’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.3M Buy
538,196
+109,877
+26% +$7.25M 0.05% 281
2026
Q1
$29.5M Sell
428,319
-45,576
-10% -$3.56M 0.05% 310
2025
Q4
$41.8M Sell
473,895
-44,768
-9% -$3.81M 0.06% 250
2025
Q3
$43.2M Sell
518,663
-53,548
-9% -$4.66M 0.07% 238
2025
Q2
$53.5M Sell
572,211
-30,015
-5% -$2.84M 0.09% 196
2025
Q1
$63.7M Buy
602,226
+56,080
+10% +$5.79M 0.12% 157
2024
Q4
$52.8M Buy
546,146
+181,228
+50% +$18.1M 0.1% 198
2024
Q3
$36.1M Sell
364,918
-5,023
-1% -$460K 0.07% 268
2024
Q2
$31.8M Sell
369,941
-15,137
-4% -$1.19M 0.06% 283
2024
Q1
$29.2M Sell
385,078
-15,443
-4% -$1.19M 0.06% 317
2023
Q4
$30.4M Buy
400,521
+46,335
+13% +$3.23M 0.07% 290
2023
Q3
$24.4M Buy
+354,186
New +$25.5M 0.06% 282

Other funds holding MMSI

Aberdeen Group's MMSI Position: Q2 2026 in Review

Aberdeen Group increased its Merit Medical Systems (MMSI) stake by 26% in Q2 2026, buying an estimated $7.25M and bringing the position to 538,196 shares worth $37.3M. The position accounts for 0.05% of the portfolio, ranked #281.

Aberdeen Group first reported a position in MMSI in Q3 2023 and has held it in 12 quarters since. The position peaked at $63.7M in Q1 2025. 405 funds tracked by Wall St. Rank hold MMSI as of Q2 2026.

  • Aberdeen Group held 538,196 shares of Merit Medical Systems worth $37.3M as of Q2 2026.
  • Aberdeen Group bought 109,877 Merit Medical Systems shares in Q2 2026, an estimated $7.25M.
  • Merit Medical Systems made up 0.05% of Aberdeen Group's portfolio in Q2 2026, its #281 holding.
  • Aberdeen Group first reported a position in Merit Medical Systems in Q3 2023 and has held it in 12 quarters since.
  • Aberdeen Group's Merit Medical Systems position peaked at $63.7M in Q1 2025.
  • 405 funds tracked by Wall St. Rank held Merit Medical Systems as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.